Patients with no pre-existing cognitive impairment who developed PSCI were defined as cases, and controls were matched for age and sex
Improvement of glucose tolerance by food factors having glucagon-like peptide-1 releasing activity
Indications include: Management of liver diseases, including alcoholic liver disease, fatty liver, and hepatitis Detoxification support for patients exposed to toxins, heavy metals, or chemotherapy Adjunct therapy in neurodegenerative diseases, such as Parkinsons disease Skin brightening (off-label use in some regions) Supportive therapy in chronic fatigue syndrome and oxidative stress-related conditions Dosage and Administration Administration route: Intravenous (IV) or intramuscular (IM) Dosage: For liver support: 600 mg IV/IM daily or as prescribed For detoxification: 6001200 mg IV, 23 times per week For skin brightening (off-label): 6001200 mg IV once or twice weekly, often combined with Vitamin C Preparation: Reconstitute the powder with 4 ml of sterile diluent
[DOI] [PubMed] [Google Scholar] Liu JJ, Lin SH, Xu PL, Wang XJ, Bai JG